Riley Brigit
- SEC CIK
- 0001882857
No open-market purchases or sales filed in the past year.
Current role at each company
- ADVM Adverum Biotechnologies, Inc.Chief Scientific Officeras of Mar 17, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Riley Brigit as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2023 (view filing) | Mar 15 | 2 days | Riley BrigitChief Scientific Officer | SSale | −7.30K | $0.78 | −$5.69K | −5.9%117.4K after | |
| Sep 21, 2022 (view filing) | Sep 19 | 2 days | Riley BrigitChief Scientific Officer | SSale | −7.27K | $1.07 | −$7.77K | −5.8%118.7K after |